Literature DB >> 50401

Suppression of in vitro antibody response by a serum factor (SAA) in experimentally induced amyloidosis.

M D Benson, M A Aldo-Benson, T Shirahama, Y Borel, A S Cohen.   

Abstract

Serum from CBA/J mice made amyloidotic by chronic casein injections has been shown to suppress in vitro antibody response to SRBC. Similar suppression was also found with normal mouse serum but to a much lesser degree. This suppressive activity of both amyloidotic serum and normal serum was removed by absorption of the sera with antiserum to protein AA, the major constituent of casein-induced (secondary) amyloid fibrils. This antiserum to the amyloid fibril protein AA (mol wt 8,400 daltons) detects an immunologically cross-reacting serum alpha globulin (SAA) (mol wt approx. 100,000). It is postulated that the serum factor (SAA) is a regulator of antibody response and may be present in elevated amounts as the result of chronic antigenic stimulation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50401      PMCID: PMC2189878          DOI: 10.1084/jem.142.1.236

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Immune response suppression by an inhibitor in normal and immune mouse serum.

Authors:  B C Veit; J G Michael
Journal:  Nat New Biol       Date:  1972-02-23

2.  Age-associated changes of an amyloid related serum component.

Authors:  C J Rosenthal; E C Franklin
Journal:  Trans Assoc Am Physicians       Date:  1974

3.  Murine amyloidosis: immunologic characterization of amyloid fibril protein.

Authors:  C Isersky; D L Page; P Cuatrecasas; R A DeLellis; G G Glenner
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

4.  Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses.

Authors:  G G Glenner; W Terry; M Harada; C Isersky; D Page
Journal:  Science       Date:  1971-06-11       Impact factor: 47.728

5.  Characterization of an immunosuppressive factor present in mouse serum.

Authors:  B Veit; J G Michael
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

6.  Casein-induced experimental amyloidosis. III. Response to mitogens, allogeneic cells, and graft-versus-host reactions in the murine model.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Immunology       Date:  1974-11       Impact factor: 7.397

7.  The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils.

Authors:  M Levin; E C Franklin; B Frangione; M Pras
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

8.  A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils.

Authors:  G Husby; J B Natvig
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

9.  Isolation and identification by sequence analysis of experimentally induced guinea pig amyloid fibrils.

Authors:  M Skinner; E S Cathcart; A S Cohen; M D Benson
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

10.  Blockage of amyloid induction by colchicine in an animal model.

Authors:  T Shirahama; A S Cohen
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  13 in total

1.  Conformational flexibility of the serum amyloid precursor SAA.

Authors:  J D Sipe; K P McAdam; B F Torain; G G Glenner
Journal:  Br J Exp Pathol       Date:  1976-10

2.  Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.

Authors:  J H Morse; L D Witte; D S Goodman
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

Review 3.  Suppressor lipid-protein complexes of normal human serum.

Authors:  R L Wolf
Journal:  Surv Immunol Res       Date:  1982

4.  Effects of amyloid induction on plasma protein turnover, and its implication.

Authors:  R Kisilevsky; M Axelrad; S Brunet; M Richards
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

5.  Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.

Authors:  K P McAdam; R J Elin; J D Sipe; S M Wolff
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

6.  Casein-induced experimental amyloidosis. VI. A pathogenic role for b cells in the murine model.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

7.  Kinetics of serum amyloid protein A in casein-induced murine amyloidosis.

Authors:  M D Benson; M A Scheinberg; T Shirahama; E S Cathcart; M Skinner
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

8.  Regulation of serum amyloid A gene expression in Syrian hamsters by cytokines.

Authors:  S B Dowton; C N Peters; J J Jestus
Journal:  Inflammation       Date:  1991-10       Impact factor: 4.092

9.  Suppression of in vitro antibody response of human peripheral blood lymphocytes by a heat-labile factor in normal human serum.

Authors:  M A Aldo-Benson; B H Petersen; M D Benson
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

10.  Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein.

Authors:  K P McAdam; J D Sipe
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.